GO:0015823 phenylalanine transport: Amino Acid Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015823 phenylalanine transport describes the directed movement of phenylalanine (2-amino-3-phenylpropanoic acid) into, out of, or within a cell, or between cells, via transporters or pores.
• Key transporters include SLC6A15, LAT1 (SLC7A5/SLC3A2), OATP3A1 (SLCO3A1), and the tyrosine-phenylalanine transport system in bacteria.
• Phenylalanine transport is essential for melanogenesis, as UVB enhances SLC6A15-mediated phenylalanine transport to promote melanin synthesis.
• LAT1 (SLC7A5) mediates phenylalanine transport through a molecular mechanism involving conformational changes and substrate binding, as revealed by molecular dynamics simulations.
• OATP3A1 (SLCO3A1) transports aromatic amino acids including L-tryptophan, L-tyrosine, and L-phenylalanine, linking phenylalanine transport to broader amino acid homeostasis.
• Dysregulated phenylalanine transport is implicated in metabolic disorders, cancer, and pigmentation disorders, making it a target for CRISPR-based functional studies.
Description
Phenylalanine transport (GO:0015823) is a biological process defined as the directed movement of phenylalanine, 2-amino-3-phenylpropanoic acid, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is fundamental for maintaining intracellular amino acid pools, supporting protein synthesis, and serving as a precursor for neurotransmitters and melanin. Researchers study phenylalanine transport to understand metabolic disorders, cancer metabolism, and pigmentation biology, as well as to develop targeted therapies. The transport of phenylalanine is mediated by specific membrane proteins, including SLC6A15, LAT1 (SLC7A5/SLC3A2), and OATP3A1 (SLCO3A1), each with distinct tissue distributions and regulatory mechanisms. In bacteria such as Bacillus subtilis, a specific tyrosine-phenylalanine transport system has been characterized, highlighting evolutionary conservation of aromatic amino acid transport. Additionally, phenylalanine transport is exploited in boron neutron capture therapy, where p-borono-phenylalanine is transported through the cell membrane. Understanding the molecular details of phenylalanine transport is crucial for developing interventions in diseases ranging from phenylketonuria to melanoma.
phenylalanine transport At A Glance
| GO ID | GO:0015823 |
|---|---|
| GO term | phenylalanine transport |
| Ontology | biological_process |
| Synonym | L-phenylalanine transport |
| Major function | Directed movement of phenylalanine across membranes via transporters or pores |
| Key transporters | SLC6A15, LAT1 (SLC7A5/SLC3A2), OATP3A1 (SLCO3A1), bacterial tyrosine-phenylalanine transport system |
| Tissue distribution | Broad; prominent in brain, placenta, melanoma, and intestinal epithelium |
| Related diseases | Pigmentation disorders, cancer, metabolic disorders, boron neutron capture therapy |
| Research methods | Molecular dynamics, transport assays, CRISPR knockout, overexpression, imaging |
What Is GO:0015823?
GO:0015823 phenylalanine transport is the biological process by which phenylalanine, an essential aromatic amino acid, is moved across cellular membranes or within cellular compartments. This movement is facilitated by transporter proteins or pores and can occur into, out of, or between cells. The process is distinct from phenylalanine metabolism and is critical for supplying phenylalanine for protein synthesis and as a precursor for tyrosine, dopamine, norepinephrine, and melanin.
Why Is phenylalanine transport Important in Cell Biology?
Phenylalanine transport is vital for cellular amino acid homeostasis and serves as a gateway for phenylalanine-dependent processes such as melanogenesis, neurotransmitter synthesis, and protein translation. Dysregulation of phenylalanine transporters is associated with pigmentation disorders, cancer progression, and metabolic diseases, making these transporters attractive therapeutic targets. Moreover, phenylalanine transport is exploited in boron neutron capture therapy, where p-borono-phenylalanine uptake determines treatment efficacy. Understanding the molecular mechanisms of phenylalanine transport can inform the development of inhibitors or modulators for clinical applications.
• Supplies phenylalanine for protein synthesis and as a precursor for tyrosine, dopamine, and melanin.
• UVB-induced SLC6A15-mediated phenylalanine transport promotes melanogenesis, linking transport to skin pigmentation.
• LAT1 (SLC7A5) is overexpressed in many cancers and transports phenylalanine to support tumor growth.
• OATP3A1 (SLCO3A1) transports aromatic amino acids, affecting drug pharmacokinetics and amino acid homeostasis.
• Bacterial tyrosine-phenylalanine transport systems are models for studying aromatic amino acid uptake and antibiotic development.
• p-Borono-phenylalanine transport is critical for boron neutron capture therapy of tumors.
• Phenylalanine transport defects may contribute to metabolic disorders such as phenylketonuria.
• Transporters are potential targets for modulating immune responses and neurological functions.
What Happens During phenylalanine transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and grabs phenylalanine.
Phenylalanine transport begins with the specific binding of phenylalanine to a transporter protein. For example, LAT1 (SLC7A5) forms a heterodimeric complex with SLC3A2 (4F2hc) and binds phenylalanine with high affinity, as shown by molecular dynamics simulations. OATP3A1 (SLCO3A1) also binds aromatic amino acids including L-phenylalanine, although with broader specificity. In Bacillus subtilis, a dedicated tyrosine-phenylalanine transport system recognizes both amino acids. The binding site typically involves aromatic residues that accommodate the phenyl ring of phenylalanine.
Conformational Changes and Translocation
In simple terms: The transporter changes shape to move phenylalanine across the membrane.
Upon substrate binding, transporters undergo conformational changes to translocate phenylalanine across the lipid bilayer. Molecular dynamics studies of LAT1 reveal that phenylalanine transport involves a rocker-switch mechanism, where the transporter alternates between outward-facing and inward-facing states. Steered molecular dynamics simulations have provided insights into the energy barriers and pathways of phenylalanine movement through LAT1. Similarly, OATP3A1-mediated transport likely involves a similar alternating-access mechanism, although structural details remain to be fully elucidated.
Regulation by UVB and Cellular Signals
In simple terms: External signals like UVB can boost phenylalanine transport.
Phenylalanine transport can be regulated by extracellular stimuli. UVB irradiation enhances SLC6A15-mediated phenylalanine transport in melanocytes, leading to increased melanin synthesis. This regulation likely involves transcriptional upregulation of SLC6A15 or post-translational modifications, although the exact mechanism requires further study. Such regulation links environmental factors to amino acid transport and pigmentation.
Intracellular Fate of Phenylalanine
In simple terms: Once inside, phenylalanine is used for building proteins or other molecules.
After transport into the cell, phenylalanine can be incorporated into proteins or converted to tyrosine by phenylalanine hydroxylase, which is then used for dopamine and melanin synthesis. In melanoma cells, phenylalanine transported via SLC6A15 contributes to melanogenesis. In cancer cells, phenylalanine transported by LAT1 supports protein synthesis and cell proliferation. Thus, phenylalanine transport is tightly coupled to downstream metabolic pathways.
Key Genes Involved in GO:0015823 phenylalanine transport
The following genes encode transporters and related proteins that mediate or regulate phenylalanine transport (GO:0015823).
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A15 | Sodium-dependent neutral amino acid transporter; mediates phenylalanine transport in melanocytes | UVB-induced melanogenesis; knockout reduces melanin |
| SLC7A5 (LAT1) | Light chain of the L-type amino acid transporter; transports phenylalanine and other large neutral amino acids | Cancer metabolism; molecular dynamics studies |
| SLC3A2 (4F2hc) | Heavy chain of LAT1; required for LAT1 surface expression and function | Essential for LAT1-mediated phenylalanine transport |
| SLCO3A1 (OATP3A1) | Organic anion transporting polypeptide; transports aromatic amino acids including phenylalanine | Drug transport; amino acid homeostasis |
| PAH | Phenylalanine hydroxylase; converts phenylalanine to tyrosine after transport | Phenylketonuria; melanin synthesis |
| TYR | Tyrosinase; uses tyrosine (derived from phenylalanine) for melanin synthesis | Pigmentation disorders |
| SLC7A8 (LAT2) | L-type amino acid transporter; transports phenylalanine in kidney and intestine | Amino acid reabsorption; potential redundancy with LAT1 |
| SLC16A10 (TAT1) | Aromatic amino acid transporter; transports phenylalanine, tyrosine, and tryptophan | Thyroid hormone synthesis; amino acid transport |
| SLC43A1 (LAT3) | L-type amino acid transporter; transports phenylalanine and other branched-chain amino acids | Cancer and metabolic studies |
| SLC43A2 (LAT4) | L-type amino acid transporter; transports phenylalanine in placenta and brain | Fetal development; neurological function |
| SLC1A4 (ASCT1) | Neutral amino acid transporter; transports phenylalanine in brain | Neurotransmitter precursor supply |
| SLC1A5 (ASCT2) | Neutral amino acid transporter; transports phenylalanine and glutamine | Cancer metabolism; mTOR activation |
| SLC38A2 (SNAT2) | Sodium-coupled neutral amino acid transporter; transports phenylalanine | Cell growth; amino acid sensing |
| SLC38A4 (SNAT4) | Sodium-coupled neutral amino acid transporter; transports phenylalanine in liver | Liver metabolism |
| SLC6A19 (B0AT1) | Neutral amino acid transporter; transports phenylalanine in intestine and kidney | Hartnup disorder; amino acid absorption |
| SLC25A22 | Mitochondrial glutamate carrier; indirectly affects phenylalanine metabolism | Mitochondrial transport; metabolic disorders |
| SLC3A1 | Heavy chain of amino acid transporters; partners with LAT2 | Cystinuria; amino acid transport |
| SLC7A9 | Light chain of amino acid transporter; partners with SLC3A1 | Cystinuria; amino acid transport |
How Is phenylalanine transport Regulated?
Phenylalanine transport is regulated at multiple levels. Transcriptional regulation of SLC6A15 by UVB exposure enhances phenylalanine uptake in melanocytes. The activity of LAT1 (SLC7A5) is regulated by its association with SLC3A2 and by intracellular signaling pathways such as mTOR, which promotes cell growth and increases amino acid demand. OATP3A1 (SLCO3A1) activity can be modulated by substrate availability and potentially by phosphorylation. In bacteria, the tyrosine-phenylalanine transport system is subject to feedback inhibition by intracellular amino acids. Additionally, hormonal signals and nutrient status can influence the expression of amino acid transporters, although specific mechanisms for phenylalanine transporters require further investigation.
phenylalanine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A15 | Pigmentation disorders, melanoma | Knockout melanocytes, UVB treatment |
| SLC7A5 (LAT1) | Cancer (e.g., glioma, breast cancer) | Knockout cancer cell lines, xenograft models |
| SLCO3A1 (OATP3A1) | Drug transport, metabolic disorders | Overexpression in HEK293 cells, transport assays |
| PAH | Phenylketonuria | Point mutation knock-in mice, hepatocytes |
| SLC6A19 | Hartnup disorder | Knockout mice, intestinal organoids |
Phenylalanine Transport in Melanogenesis and Pigmentation Disorders
UVB irradiation enhances SLC6A15-mediated phenylalanine transport, which promotes melanin synthesis in melanocytes. This pathway is critical for skin pigmentation and photoprotection. Dysregulation of this transport process may contribute to pigmentation disorders such as vitiligo or hyperpigmentation. Targeting SLC6A15 could provide therapeutic strategies for modulating pigmentation.
Phenylalanine Transport in Cancer
LAT1 (SLC7A5) is overexpressed in many cancers and transports phenylalanine to support rapid cell proliferation. Inhibition of LAT1-mediated phenylalanine transport reduces tumor growth in preclinical models. Molecular dynamics studies have elucidated the transport mechanism, aiding the design of specific inhibitors. OATP3A1 (SLCO3A1) also transports phenylalanine and may influence drug uptake in cancer cells.
Phenylalanine Transport in Metabolic Disorders
Defects in phenylalanine transport can contribute to metabolic disorders such as phenylketonuria, where phenylalanine accumulates due to impaired metabolism, and transport across the blood-brain barrier affects neurological outcomes. Additionally, mutations in amino acid transporters like SLC6A19 cause Hartnup disorder, characterized by defective neutral amino acid transport including phenylalanine.
Phenylalanine Transport in Boron Neutron Capture Therapy
p-Borono-phenylalanine (BPA) is transported into tumor cells via amino acid transporters, including LAT1, for boron neutron capture therapy. Understanding the mechanisms of phenylalanine transport is essential for optimizing BPA uptake and improving therapeutic efficacy.
From phenylalanine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC6A15 mediate phenylalanine transport in melanocytes? | SLC6A15 knockout melanocytes + phenylalanine uptake assay |
| What is the structural basis of LAT1-mediated phenylalanine transport? | Point mutations in SLC7A5 binding site + molecular dynamics |
| Can OATP3A1 transport phenylalanine in vivo? | SLCO3A1 knockout mice + pharmacokinetic studies |
| Does LAT1 overexpression increase tumor growth? | LAT1 overexpression in cancer cell lines + xenograft |
| Is SLC6A15 required for UVB-induced melanogenesis? | SLC6A15 knockout mice + UVB exposure |
| Can phenylalanine transport be targeted for boron neutron capture therapy? | Knockout of LAT1 in tumor cells + BPA uptake |
How to Study the phenylalanine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity | Comparing knockout vs wild-type cells |
| Molecular dynamics simulation | Conformational changes and binding | LAT1 transport mechanism |
| CRISPR knockout | Loss-of-function phenotype | SLC6A15 in melanogenesis |
| CRISPR knock-in | Point mutation effects | LAT1 substrate specificity |
| Immunofluorescence | Subcellular localization | Transporter trafficking |
| Proteomics | Protein interactions and modifications | Regulatory networks |
| Transport inhibitor profiling | Sensitivity to inhibitors | Drug development |
| Boron uptake assay | BPA transport | BNCT optimization |
Transport Assays
Radiolabeled or fluorescent phenylalanine uptake assays are used to measure transport activity in cells or membrane vesicles. These assays can be performed in knockout or overexpression cell lines to determine the contribution of specific transporters. For example, SLC6A15-mediated phenylalanine transport was measured in melanocytes using radiolabeled phenylalanine.
Molecular Dynamics Simulations
Molecular dynamics, steered molecular dynamics, and targeted molecular dynamics simulations provide atomic-level insights into phenylalanine transport through LAT1. These computational methods reveal conformational changes, binding energies, and translocation pathways, complementing experimental studies.
CRISPR-Cas9 Knockout and Knock-in
CRISPR-Cas9 is used to generate knockout cell lines or animal models to study the loss of function of phenylalanine transporters. Knock-in of point mutations can mimic disease-associated variants or alter substrate specificity. These models are essential for establishing causal roles of specific transporters in phenylalanine transport and downstream phenotypes.
Imaging and Proteomics
Fluorescently tagged transporters can be imaged to study subcellular localization and trafficking. Proteomics approaches can identify interaction partners and post-translational modifications of phenylalanine transporters. These methods help elucidate regulatory mechanisms and transport dynamics.
How CRISPR Can Be Used to Study GO:0015823 phenylalanine transport
Knockout
CRISPR-Cas9 knockout of SLC6A15, SLC7A5, or SLCO3A1 eliminates specific phenylalanine transport activity, allowing researchers to attribute transport to individual transporters. For example, SLC6A15 knockout melanocytes show reduced phenylalanine uptake and melanin synthesis upon UVB exposure. Knockout models are also used to study the role of LAT1 in cancer cell proliferation.
Point Mutation
CRISPR-mediated point mutations can introduce disease-associated variants or alter key residues in the transporter binding pocket. For instance, mutations in SLC7A5 (LAT1) can be generated to test their effect on phenylalanine transport kinetics and substrate specificity. Such models help validate structural predictions from molecular dynamics simulations.
Knock-in
Knock-in of tagged transporters (e.g., GFP-SLC6A15) allows real-time imaging of transporter localization and dynamics. Knock-in of human transporter genes into mouse models can humanize the transport system for drug testing. These models are valuable for studying tissue-specific transport and regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of transporters like LAT1 or OATP3A1 increases phenylalanine transport capacity, enabling studies of transport kinetics and downstream metabolic effects. Overexpression models are used to screen for inhibitors or to study transport in cancer cells.
How EDITGENE Supports phenylalanine transport Research
Researchers studying phenylalanine transport-related genes often need to determine whether a candidate gene is causally involved in transport, how mutations affect transporter function, and whether modulating its expression alters cellular phenotypes. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for phenylalanine transport research.
Frequently Asked Questions About phenylalanine transport
What is phenylalanine transport (GO:0015823)?
Phenylalanine transport is the directed movement of phenylalanine across cellular membranes via transporters or pores, as defined by GO:0015823.
What genes are involved in phenylalanine transport?
Key genes include SLC6A15, SLC7A5 (LAT1), SLC3A2, SLCO3A1 (OATP3A1), and SLC6A19, among others.
How is phenylalanine transport regulated?
It is regulated by UVB exposure (SLC6A15), mTOR signaling (LAT1), and substrate availability, as well as transcriptional and post-translational mechanisms.
What diseases are associated with phenylalanine transport?
Diseases include pigmentation disorders, cancer, phenylketonuria, Hartnup disorder, and conditions treated with boron neutron capture therapy.
What is the role of SLC6A15 in phenylalanine transport?
SLC6A15 mediates sodium-dependent phenylalanine transport in melanocytes, and its activity is enhanced by UVB to promote melanogenesis.
How does LAT1 transport phenylalanine?
LAT1 (SLC7A5) forms a heterodimer with SLC3A2 and transports phenylalanine via an alternating-access mechanism, as shown by molecular dynamics simulations.
Can phenylalanine transport be studied with CRISPR?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to study the function of specific transporters in phenylalanine transport.
What methods are used to measure phenylalanine transport?
Radiolabeled uptake assays, molecular dynamics simulations, imaging, and proteomics are common methods.
Is phenylalanine transport important for cancer?
Yes, LAT1-mediated phenylalanine transport supports cancer cell growth and is a target for inhibitor development.
What is the clinical relevance of phenylalanine transport in boron neutron capture therapy?
p-Borono-phenylalanine uptake via amino acid transporters like LAT1 is critical for effective boron neutron capture therapy.
Conclusion
Phenylalanine transport (GO:0015823) is a fundamental biological process mediated by a diverse set of transporters, including SLC6A15, LAT1, and OATP3A1. It plays critical roles in melanogenesis, cancer metabolism, and metabolic disorders, and is exploited in boron neutron capture therapy. Understanding the molecular mechanisms and regulation of phenylalanine transport provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR services to facilitate research on phenylalanine transport-related genes, from knockout to overexpression and library screening.
References
- 1. Zhou S et al.. 2026. UVB enhances SLC6A15-mediated phenylalanine transport to promote melanogenesis.. J Photochem Photobiol B 274:113329 PMID: 41352278
- 2. Surrer DB et al.. 2024. Transport of aromatic amino acids l-tryptophan, l-tyrosine, and l-phenylalanine by the organic anion transporting polypeptide (OATP) 3A1.. FEBS J 291(21):4732-4743 PMID: 39206635
- 3. Islam SM et al.. 2026. Phenylalanine Transport through LAT1: Insights from Molecular Dynamics, Steered Molecular Dynamics, and Targeted Molecular Dynamics.. J Phys Chem B 130(29):7276-7290 PMID: 42424096
- 7. D'Ambrosio SM et al.. 1973. Specificity of the tyrosine-phenylalanine transport system in Bacillus subtilis.. J Bacteriol 115(2):673-81 PMID: 4199137
- 8. Wittig A et al.. 2000. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro.. Radiat Res 153(2):173-80 PMID: 10629616
